Commercial Bank Investment and Financial Health Review slide image

Commercial Bank Investment and Financial Health Review

Group Financial Performance - Half Year Ended 30 June 2020 Group Profitability USD million Consolidated Balance Sheet H1 2020 H1 2019 % USD million H1 2020 H1 2019 % Net interest income 432 335 29.0% Total assets 39,471 38,786 1.8% Non-interest income 117 173 -32.2% Loans & advances 23,901 23,556 1.5% Total costs (129) (152) -14.9% Investment Securities 7,354 6,446 14.1% Net provisions (81) (118) -30.8% Customer Deposits 21,349 21,254 0.4% Associates income (88) 27 -424.2% Net profit after tax 248 260 -5.0% Total equity 5,957 5,626 5.9% Performance Ratios Capital H1 2020 H1 2019 H1 2020 H1 2019 ROAE ROAA NIM 8.2% 9.4% RWA (USD million) 31,073 30,817 1.2% 1.4% CET 1 ratio (Basel III) 11.5% 11.0% 2.4% 2.0% Total Capital ratio (Basel III) 17.3% 16.3% All QAR figures converted into USD at an exchange rate of USD 1 equivalent to QAR 3.64 37 65 3
View entire presentation